S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
Log in

Ingevity Stock Price, Forecast & Analysis (NYSE:NGVT)

$88.91
-1.82 (-2.01 %)
(As of 11/13/2019 01:27 PM ET)
Today's Range
$87.73
Now: $88.91
$89.38
50-Day Range
$77.79
MA: $85.49
$93.78
52-Week Range
$72.59
Now: $88.91
$120.41
Volume2,378 shs
Average Volume316,141 shs
Market Capitalization$3.72 billion
P/E Ratio21.53
Dividend YieldN/A
Beta2.09
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Previous SymbolNASDAQ:NGVT
CUSIPN/A
Phone843-740-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.13 billion
Cash Flow$5.33 per share
Book Value$8.07 per share

Profitability

Net Income$169.10 million

Miscellaneous

Employees1,750
Market Cap$3.72 billion
Next Earnings Date2/12/2020 (Estimated)
OptionableOptionable

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.


Ingevity (NYSE:NGVT) Frequently Asked Questions

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How were Ingevity's earnings last quarter?

Ingevity Corp (NYSE:NGVT) announced its quarterly earnings results on Wednesday, October, 23rd. The company reported $1.46 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.42 by $0.04. The business earned $359.90 million during the quarter, compared to analysts' expectations of $365.44 million. Ingevity had a net margin of 14.31% and a return on equity of 53.69%. The firm's revenue for the quarter was up 15.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.16 EPS. View Ingevity's Earnings History.

When is Ingevity's next earnings date?

Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Ingevity.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity updated its FY 2019 earnings guidance on Wednesday, October, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.28-1.3 billion, compared to the consensus revenue estimate of $1.33 billion.

What price target have analysts set for NGVT?

8 brokers have issued 1 year price objectives for Ingevity's stock. Their forecasts range from $99.00 to $130.00. On average, they anticipate Ingevity's stock price to reach $111.38 in the next twelve months. This suggests a possible upside of 25.3% from the stock's current price. View Analyst Price Targets for Ingevity.

What is the consensus analysts' recommendation for Ingevity?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.

Has Ingevity been receiving favorable news coverage?

Media coverage about NGVT stock has trended very negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ingevity earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Ingevity.

Are investors shorting Ingevity?

Ingevity saw a increase in short interest in September. As of September 30th, there was short interest totalling 1,110,000 shares, an increase of 11.7% from the August 30th total of 993,300 shares. Based on an average trading volume of 323,700 shares, the short-interest ratio is presently 3.4 days. Approximately 2.7% of the company's stock are short sold. View Ingevity's Current Options Chain.

Who are some of Ingevity's key competitors?

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include NVIDIA (NVDA), Costco Wholesale (COST), AbbVie (ABBV), Boeing (BA), General Electric (GE), Quaker Chemical (KWR), UnitedHealth Group (UNH), Micron Technology (MU), Paypal (PYPL) and Zebra Technologies (ZBRA).

Who are Ingevity's key executives?

Ingevity's management team includes the folowing people:
  • Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)
  • Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)
  • Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)
  • Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58)

Who are Ingevity's major shareholders?

Ingevity's stock is owned by many different of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (2.43%), Rice Hall James & Associates LLC (1.17%), Ardevora Asset Management LLP (0.75%), Copper Rock Capital Partners LLC (0.59%), Eagle Asset Management Inc. (0.53%) and Patten & Patten Inc. TN (0.41%). Company insiders that own Ingevity stock include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Institutional Ownership Trends for Ingevity.

Which major investors are selling Ingevity stock?

NGVT stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Copper Rock Capital Partners LLC, Chartwell Investment Partners LLC, Kornitzer Capital Management Inc. KS, Gateway Investment Advisers LLC, First Trust Advisors LP, Patten & Patten Inc. TN and Rhumbline Advisers. Company insiders that have sold Ingevity company stock in the last year include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Insider Buying and Selling for Ingevity.

Which major investors are buying Ingevity stock?

NGVT stock was purchased by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Massachusetts Financial Services Co. MA, Rice Hall James & Associates LLC, Tygh Capital Management Inc., Russell Investments Group Ltd., Eagle Asset Management Inc., State of New Jersey Common Pension Fund D and Congress Asset Management Co. MA. View Insider Buying and Selling for Ingevity.

How do I buy shares of Ingevity?

Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $88.91.

How big of a company is Ingevity?

Ingevity has a market capitalization of $3.72 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,750 workers across the globe.View Additional Information About Ingevity.

What is Ingevity's official website?

The official website for Ingevity is http://www.ingevity.com/.

How can I contact Ingevity?

Ingevity's mailing address is 5255 Virginia Avenue, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]


MarketBeat Community Rating for Ingevity (NYSE NGVT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  307 (Vote Outperform)
Underperform Votes:  287 (Vote Underperform)
Total Votes:  594
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Featured Article: What is the Coverage Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel